Table 3.
Any (≥37.1℃) |
Grade-2 (37.6-39.0℃) |
|||
---|---|---|---|---|
Variables | IRR (95%CI) | P | IRR (95%CI) | P |
Group2 (low-dose VS placebo) | 0.713(0.575-0.884) | 0.002 | 0.996(0.615-1.612) | 0.986 |
Group3 (high-dose VS placebo) | 0.673(0.551-0.822) | <0.001a | 1.442(0.966-2.152) | 0.073b |
Sex (male VS female) | 2.932(2.427-3.541) | <0.001 | 7.624(4.686-12.404) | <0.001 |
Agegroup | 1.071(0.984-1.166) | 0.113 | 0.783(0.668-0.919) | 0.003 |
BMI | 1.034(0.999-1.070) | 0.054 | 0.667(0.613-0.726) | <0.001 |
Base-temperature | 2.177(1.635-2.900) | <0.001 | 2.842(1.581-5.107) | <0.001 |
Time | 1.003(1.003-1.003) | <0.001 | 1.006(1.004-1.008) | <0.001 |
P = 0.607 for high-dose group versus low-dose group.
P = 0.089 for high-dose group versus low-dose group.